| Frontiers in Cell and Developmental Biology | 卷:9 |
| Ser71 Phosphorylation Inhibits Actin-Binding of Profilin-1 and Its Apoptosis-Sensitizing Activity | |
| Shirong Cai1  Faliang Wang3  Jieya Shao4  Sun-Joong Kim4  Cuige Zhu4  Aaron Boudreau5  Mina Bissell5  | |
| [1] Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States; | |
| [2] Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO, United States; | |
| [3] Department of Surgical Oncology, The Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China; | |
| [4] Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States; | |
| [5] Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, United States; | |
| 关键词: profilin-1; phosphorylation; actin; poly-L-proline; apoptosis; breast cancer; | |
| DOI : 10.3389/fcell.2021.692269 | |
| 来源: DOAJ | |
【 摘 要 】
The essential actin-binding factor profilin-1 (Pfn1) is a non-classical tumor suppressor with the abilities toboth inhibit cellular proliferation and augment chemotherapy-induced apoptosis. Besides actin, Pfn1 interacts with proteins harboring the poly-L-proline (PLP) motifs. Our recent work demonstrated that both nuclear localization and PLP-binding are required for tumor growth inhibition by Pfn1, and this is at least partially due to Pfn1 association with the PLP-containing ENL protein in the Super Elongation Complex (SEC) and the transcriptional inhibition of pro-cancer genes. In this paper, by identifying a phosphorylation event of Pfn1 at Ser71 capable of inhibiting its actin-binding and nuclear export, we provide in vitro and in vivo evidence that chemotherapy-induced apoptotic sensitization by Pfn1 requires its cytoplasmic localization and actin-binding. With regard to tumor growth inhibition byPfn1, our data indicate a requirement for dynamic actin association and dissociation rendered by reversible Ser71phosphorylation and dephosphorylation. Furthermore, genetic and pharmacological experiments showed that Ser71 of Pfn1 can be phosphorylated by protein kinase A (PKA). Taken together, our data provide novel mechanistic insights into the multifaceted anticancer activities of Pfn1 and how they are spatially-defined in the cell and differentially regulated by ligand-binding.
【 授权许可】
Unknown